Skip to main content
. 2013 Oct 24;347:f6008. doi: 10.1136/bmj.f6008

graphic file with name wuh006956.f3_default.jpg

Fig 3 Ranking of treatment strategies based on probability of their protective effects on outcomes of all cause mortality, end stage renal disease, and doubling of serum creatinine levels. Angiotensin receptor blocker (ARB) plus calcium channel blocker (CCB); ARB plus diuretic, and angiotensin converting enzyme (ACE) inhibitor plus ARB were not ranked owing to wide credible intervals